Holen Sie sich die Stockscreener-App
85.12
0.84%
0.31
Schlusskurs vom Vortag:
$84.81
Offen:
$85.26
24-Stunden-Volumen:
1.22M
Relative Volume:
0.92
Marktkapitalisierung:
$11.58B
Einnahmen:
$2.94B
Nettoeinkommen (Verlust:
$537.87M
KGV:
21.64
EPS:
3.9341
Netto-Cashflow:
$579.02M
1W Leistung:
+7.00%
1M Leistung:
-9.85%
6M Leistung:
-6.10%
1J Leistung:
+45.05%
1-Tages-Spanne:
$84.03
$85.73
1-Wochen-Bereich:
$80.30
$86.02
52-Wochen-Spanne:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
85.29 | 11.51B | 2.94B | 537.87M | 579.02M | 3.9341 |
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.11 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.83 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.84 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.75 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Hochstufung | Needham | Hold → Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-11-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-07 | Hochstufung | Truist | Hold → Buy |
| 2025-10-28 | Fortgesetzt | Stifel | Hold |
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Wells Fargo Cuts PT on Globus Medical (GMED) Despite Q1 Sales and EPS Beat - Insider Monkey
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $103 to $117 - Moomoo
Globus Medical, Inc. (GMED) Stock Report: Analyzing a 30.98% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Globus Medical’s SWOT analysis: stock gains momentum on spine growth By Investing.com - Investing.com India
Globus Medical’s SWOT analysis: stock gains momentum on spine growth - Investing.com
At US$84.61, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List? - 富途牛牛
Is It Time To Reassess Globus Medical (GMED) After Recent Share Price Swings? - Sahm
Zacks Industry Outlook Highlights Electromed, Globus Medical and Intuitive Surgical - Zacks Investment Research
Globus Medical Uses Generative AI And M&A To Reshape Growth Profile - Yahoo Finance
GMED Stock Price, Quote & Chart | GLOBUS MEDICAL INCA (NYSE:GMED) - ChartMill
3 Medical Instrument Stocks Exploring GenAI to Tackle Industry Woes - TradingView
Globus Medical Inc (GMED) Shares Surge 5.1% -- What GF Score of 97 Tells Investors - GuruFocus
Jim Cramer on Globus Medical: “There Is Not a Lot of Money to Be Made in This One” - Insider Monkey
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term - Yahoo Finance
Bull of the Day: Globus Medical (GMED) - The Globe and Mail
Globus Medical and Conagra Brands have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research
Globus Medical IncA (NYSE:GMED) Passes Navellier's Little Book Screen - ChartMill
Globus Medical stock price target lowered to $87 by Freedom Broker - Investing.com UK
Needham Raises its Price Target on Globus Medical (GMED) - Insider Monkey
Globus Medical Q1 earnings call highlights - MSN
5 Must-Read Analyst Questions From Globus Medical’s Q1 Earnings Call - Yahoo Finance
Citizens reiterates Globus Medical stock rating after Q1 beat By Investing.com - Investing.com Canada
Globus Medical, Inc. (GMED) Investor Outlook: Exploring a 45.49% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Globus Medical, Inc. $GMED Shares Acquired by Northwestern Mutual Wealth Management Co. - MarketBeat
Is Reaffirmed 2026 Guidance and Capital Allocation Shifting the Investment Case for Globus Medical (GMED)? - Sahm
VIRGINIA RETIREMENT SYSTEMS ET Al Sells 17,300 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED) Valuation Check After Share Price Drop And Solid Quarterly Results - Sahm
GMED Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Intramedullary Nail Leg Lengthening Market Size, & Report 2033 - UnivDatos
Globus Medical tanks 8% despite beating estimates for top and bottom lines - MSN
8-Day Sell-Off Sends Globus Medical Stock Down -17% - Trefis
Globus Medical Stock Slides 17% With A 8-Day Losing Spree - Trefis
Globus Medical Stock In Shambles: Down 17% With 7-Day Losing Streak - Trefis
7-Day Sell-Off Sends Globus Medical Stock Down -17% - Trefis
Canaccord Genuity maintains Globus Medical (GMED) buy recommendation - MSN
Stifel Nicolaus Reaffirms Their Hold Rating on Globus Medical (GMED) - The Globe and Mail
Research Alert: CFRA Keeps Hold Opinion On Shares Of Globus Medical Inc. - Moomoo
Globus Medical (GMED) Valuation Check After Strong Q1 2026 Earnings Beat And Raised Guidance - Yahoo Finance
3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED) - sharewise.com
Down 13.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Globus Medical (GMED) - Yahoo Finance
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):